Comparative study of Wuhan-like and omicron-like variants of SARS-CoV-2 in experimental animal models

Comparative study of Wuhan-like and omicron-like variants of SARS-CoV-2 in experimental animal models

Introduction. The variability of SARS-CoV-2 appeared to be higher than expected, the emergence of new variants raises concerns. The aim of the work was to compare the pathogenicity of the Wuhan and BA.1.1/Omicron variants in BALB/c mice and Syrian hamsters. Materials and methods. The study use...

Full description

Bibliographic Details
Main Authors:	Irina A. Leneva, Daria I. Smirnova, Nadezhda P. Kartashova, Anastasiia V. Gracheva, Anna V. Ivanina, Ekaterina A. Glubokova, Ekaterina R. Korchevaya, Andrey A. Pancratov, Galina V. Trunova, Varvara A. Khokhlova, Oksana A. Svitich, Vitaly V. Zverev, Evgeny B. Faizuloev
Format:	Article
Language:	English
Published:	Central Research Institute for Epidemiology 2022-11-01
Series:	Вопросы вирусологии
Subjects:	sars-cov-2 variants balb/c mice transgenic b6.cg-tg(k18-ace2)2prlmn/hemi hemizygous for tg(k18-ace2)2prlmn mice syrian golden hamsters sars-cov-2 animal models
Online Access:	https://virusjour.crie.ru/jour/article/viewFile/627/416

Similar Items

Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection
by: Sabrina Clever, et al.
Published: (2024-03-01)

Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits
by: Sung-Hee Kim, et al.
Published: (2022-11-01)

Corrigendum: Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits
by: Sung-Hee Kim, et al.
Published: (2022-12-01)

Prolonged Protective Immunity Induced by Mild SARS-CoV-2 Infection of K18-hACE2 Mice
by: Liat Bar-On, et al.
Published: (2022-04-01)

A longitudinal molecular and cellular lung atlas of lethal SARS-CoV-2 infection in K18-hACE2 transgenic miceResearch in context
by: Seunghoon Choi, et al.
Published: (2024-01-01)

Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice
by: Pratima Kumari, et al.
Published: (2021-01-01)

SARS-CoV-2 Infects Primary Neurons from Human ACE2 Expressing Mice and Upregulates Genes Involved in the Inflammatory and Necroptotic Pathways
by: Hussin A. Rothan, et al.
Published: (2022-02-01)

Effective protection of ZF2001 against the SARS-CoV-2 Delta variant in lethal K18-hACE2 mice
by: Lianlian Bian, et al.
Published: (2022-05-01)

Chimeric Virus-like Particle-Based COVID-19 Vaccine Confers Strong Protection against SARS-CoV-2 Viremia in K18-hACE2 Mice
by: Challika Kaewborisuth, et al.
Published: (2022-05-01)

A siRNA targets and inhibits a broad range of SARS‐CoV‐2 infections including Delta variant
by: Yi‐Chung Chang, et al.
Published: (2022-04-01)

Early pathogenesis profiles across SARS-CoV-2 variants in K18-hACE2 mice revealed differential triggers of lung damages
by: Zhen Qin Aw, et al.
Published: (2022-10-01)

Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models
by: Haengdueng Jeong, et al.
Published: (2022-11-01)

SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids
by: Romal Stewart, et al.
Published: (2023-11-01)

Mouse-Adapted SARS-CoV-2 MA10 Strain Displays Differential Pulmonary Tropism and Accelerated Viral Replication, Neurodissemination, and Pulmonary Host Responses in K18-hACE2 Mice
by: Côme J. Thieulent, et al.
Published: (2023-02-01)

Emerging Role of Kinin B1 Receptor in Persistent Neuroinflammation and Neuropsychiatric Symptoms in Mice Following Recovery from SARS-CoV-2 Infection
by: Srinivas Sriramula, et al.
Published: (2023-08-01)

Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?
by: Karim Bendjelid
Published: (2020-07-01)

Upper Respiratory Infection Drives Clinical Signs and Inflammatory Responses Following Heterologous Challenge of SARS-CoV-2 Variants of Concern in K18 Mice
by: Jacob H. Nichols, et al.
Published: (2023-04-01)

Immunodominant Linear B-Cell Epitopes of SARS-CoV-2 Spike, Identified by Sera from K18-hACE2 Mice Infected with the WT or Variant Viruses
by: Yinon Levy, et al.
Published: (2022-02-01)

K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
by: Simona Dedoni, et al.
Published: (2022-06-01)

SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling
by: Thankamani Karthika, et al.
Published: (2021-07-01)

Susceptibility of the Elderly to SARS-CoV-2 Infection: ACE-2 Overexpression, Shedding, and Antibody-dependent Enhancement (ADE)
by: Jean Pierre Schatzmann Peron, et al.

Induction of Innate Immune Response by TLR3 Agonist Protects Mice against SARS-CoV-2 Infection
by: Hadas Tamir, et al.
Published: (2022-01-01)

WERE SARS-COV-2 OR ACE-I RESPONSIBLE FOR ANGIOEDEMA OR WAS IT CAUSED BY A SECOND STRIKE? A CASE REPORT
by: Giorgio Monteleone
Published: (2023-10-01)

VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 Variants
by: Yfat Yahalom-Ronen, et al.
Published: (2023-06-01)

Expression of SARS-CoV-2 receptor ACE2 and the protease TMPRSS2 suggests susceptibility of the human embryo in the first trimester
by: Bailey A. T. Weatherbee, et al.
Published: (2020-08-01)

ACE-2-like enzymatic activity is associated with immunoglobulin in COVID-19 patients
by: Yufeng Song, et al.
Published: (2024-04-01)

Fast and Accurate Surrogate Virus Neutralization Test Based on Antibody-Mediated Blocking of the Interaction of ACE2 and SARS-CoV-2 Spike Protein RBD
by: Denis E. Kolesov, et al.
Published: (2022-02-01)

Importance of ACE2 for SARS-CoV-2 Infection of Kidney Cells
by: Marie-Kristin Kroll, et al.
Published: (2023-03-01)

Bioengineered probiotics to control SARS-CoV-2 infection
by: Shantibhusan Senapati, et al.
Published: (2020-05-01)

The importance of smell and taste in everyday life: Dysfunction in COVID-19 patients
by: Stanojlović Olivera
Published: (2021-01-01)

Are new genome variants detected in SARS-CoV-2 expected considering population dynamics in viruses?
by: Ergoren Mahmut Cerkez, et al.
Published: (2021-01-01)

Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity
by: Ramachandran Thiruvengadam, et al.
Published: (2023-10-01)

Differential Pathogenesis of SARS-CoV-2 Variants of Concern in Human ACE2-Expressing Mice
by: Janhavi Prasad Natekar, et al.
Published: (2022-05-01)

A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration
by: Xilin Wu, et al.
Published: (2021-10-01)

Virulence Profiles of Wild-Type, P.1 and Delta SARS-CoV-2 Variants in K18-hACE2 Transgenic Mice
by: Yasmin da Silva Santos, et al.
Published: (2023-04-01)

Analysis of spike protein variants evolved in a novel in vivo long-term replication model for SARS-CoV-2
by: Dongbum Kim, et al.
Published: (2023-11-01)

Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 miceResearch in context
by: Jiang-Feng Liu, et al.
Published: (2023-04-01)

Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2
by: Joseph W. Golden, et al.
Published: (2022-02-01)

Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus
by: Irina Leneva, et al.
Published: (2021-08-01)

Could the SARS-CoV-2 Infection be Acquired via the Eye?
by: Siukan Law, et al.
Published: (2021-09-01)